Found: 69
Select item for more details and to access through your institution.
The Influence of Myocardial Temperature on Stunning following Coronary Revascularizationa.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 793, n. 1, p. 319, doi. 10.1111/j.1749-6632.1996.tb33524.x
- By:
- Publication type:
- Article
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 714, doi. 10.1007/s10637-010-9556-6
- By:
- Publication type:
- Article
Extended dosing with CC‐486 (oral azacitidine) in patients with myeloid malignancies.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1199, doi. 10.1002/ajh.25216
- By:
- Publication type:
- Article
Recognition of early mortality in multiple myeloma by a prediction matrix.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 915, doi. 10.1002/ajh.24796
- By:
- Publication type:
- Article
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 460, doi. 10.1002/ajh.24687
- By:
- Publication type:
- Article
n-Dodecyl-β- d-Maltoside Inhibits Aggregation of Human Interferon-β-1b and Reduces Its Immunogenicity.
- Published in:
- Journal of NeuroImmune Pharmacology, 2011, v. 6, n. 1, p. 158, doi. 10.1007/s11481-010-9226-7
- By:
- Publication type:
- Article
Clinical Benefits and Economic Analysis of Pegylated Liposomal Doxorubicin/Vincristine/Dexamethasone Versus Doxorubicin/Vincristine/Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S150
- By:
- Publication type:
- Article
Exploring Antidepressant Adherence at a Student-Run Free Mental Health Clinic.
- Published in:
- Community Mental Health Journal, 2019, v. 55, n. 1, p. 57, doi. 10.1007/s10597-018-0301-5
- By:
- Publication type:
- Article
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 853, doi. 10.1007/s40265-018-0919-1
- By:
- Publication type:
- Article
Real-World Noninterventional Studies: Multiple Myeloma Paves the Way for Improved Clinical Trial Design.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 3, p. 28
- By:
- Publication type:
- Article
Improved differential diagnosis of intracardiac and extracardiac shunts using acoustic intensity mapping of saline contrast studies.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2020, v. 21, n. 3, p. 307, doi. 10.1093/ehjci/jez129
- By:
- Publication type:
- Article
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
- By:
- Publication type:
- Article
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
- By:
- Publication type:
- Article
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 149, doi. 10.1016/j.clml.2021.08.007
- By:
- Publication type:
- Article
P-214: Sequencing of treatment regimens after lenalidomide (LEN) in patients with multiple myeloma (MM) in a US community oncology setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S157, doi. 10.1016/S2152-2650(21)02341-7
- By:
- Publication type:
- Article
P-208: Ongoing trials investigating in-class transition (iCT) from parenteral to oral proteasome inhibitor (PI)-based treatment with ixazomib in multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S153, doi. 10.1016/S2152-2650(21)02335-1
- By:
- Publication type:
- Article
P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02263-1
- By:
- Publication type:
- Article
Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e75, doi. 10.1016/j.clml.2019.09.119
- By:
- Publication type:
- Article
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e74, doi. 10.1016/j.clml.2019.09.118
- By:
- Publication type:
- Article
Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e11, doi. 10.1016/j.clml.2019.09.015
- By:
- Publication type:
- Article
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006
- By:
- Publication type:
- Article
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
- By:
- Publication type:
- Article
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S330, doi. 10.1016/j.clml.2017.07.143
- By:
- Publication type:
- Article
Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Once-Weekly Carfilzomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: Secondary Analysis from the CHAMPION-1 Study by Prior Lines of Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e58, doi. 10.1016/j.clml.2017.03.107
- By:
- Publication type:
- Article
Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e127, doi. 10.1016/j.clml.2017.03.230
- By:
- Publication type:
- Article
Treatment Patterns From 2009-2015 in Patients With Newly Diagnosed Multiple Myeloma in the United States: A Report From the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e20, doi. 10.1016/j.clml.2017.03.035
- By:
- Publication type:
- Article
Health-Related Quality of Life (HRQoL) of Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM) Receiving Any or Lenalidomide (LEN) Maintenance After Autologous Stem Cell Transplant (ASCT) in the Connect® MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e89, doi. 10.1016/j.clml.2017.03.160
- By:
- Publication type:
- Article
Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e79, doi. 10.1016/j.clml.2017.03.144
- By:
- Publication type:
- Article
Macroesthetics: Facial and Dentofacial Analysis.
- Published in:
- Journal of the California Dental Association, 2002, v. 30, n. 11, p. 839, doi. 10.1080/19424396.2002.12223327
- By:
- Publication type:
- Article
In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00912-9
- By:
- Publication type:
- Article
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABA<sub>B</sub> Receptor-Activated GIRK Currents in VTA Dopamine Neurons.
- Published in:
- Journal of Neuroscience, 2016, v. 36, n. 11, p. 3106, doi. 10.1523/JNEUROSCI.1327-15.2016
- By:
- Publication type:
- Article
research paper Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 4, p. 470, doi. 10.1111/j.1365-2141.2004.04941.x
- By:
- Publication type:
- Article
Fade measurements on the wide bandwidth HF channel.
- Published in:
- Radio Science, 1994, v. 29, n. 5, p. 1339, doi. 10.1029/94RS00834
- By:
- Publication type:
- Article
Representation of propagation mode fading for the midlatitude wide bandwidth HF channel.
- Published in:
- Radio Science, 1994, v. 29, n. 4, p. 717, doi. 10.1029/93RS03031
- By:
- Publication type:
- Article
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
- By:
- Publication type:
- Article
Connect MM Registry as a national reference for United States multiple myeloma patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 35, doi. 10.1002/cam4.2656
- By:
- Publication type:
- Article
Maximum Shannon Information Content of Diagnostic Medical Testing.
- Published in:
- Medical Decision Making, 1985, v. 5, n. 2, p. 179, doi. 10.1177/0272989X8500500207
- By:
- Publication type:
- Article
Statistical Considerations in Medical Decision Models.
- Published in:
- Medical Decision Making, 1983, v. 3, n. 2, p. 197, doi. 10.1177/0272989X8300300208
- By:
- Publication type:
- Article
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 93, doi. 10.1111/bjh.17131
- By:
- Publication type:
- Article
Development of a prognostic model for overall survival in multiple myeloma using the Connect<sup>®</sup> MM Patient Registry.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 602, doi. 10.1111/bjh.16139
- By:
- Publication type:
- Article
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 492, doi. 10.1111/bjh.15806
- By:
- Publication type:
- Article
Diagnosis of Partial Anomalous Pulmonary Venous Connection with Intact Interatrial Septum by Echocardiography.
- Published in:
- Echocardiography, 1998, v. 15, n. 4, p. 405, doi. 10.1111/j.1540-8175.1998.tb00625.x
- By:
- Publication type:
- Article